Wuxi Pharmatech (WX) Tops Q3 EPS by 6c; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts WX Hot Sheet
Join SI Premium – FREE
Wuxi Pharmatech (NYSE: WX) reported Q3 EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $104 million versus the consensus estimate of $102.21 million.
Sees FY2011 revenue of $402-$406 million, versus the consensus of $405.23 million.
Sees FY2011 revenue of $402-$406 million, versus the consensus of $405.23 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
